Evidence map›Paper›PMID 39218043›Full record

ReviewBiochemical pharmacology2024

Ketamine - An Imperfect Wonder Drug?

Tanner Magruder, Marielle Isenhart, Maximillian V Striepe, Andrew Mannisto, Karry M Jannie, Jolene Smith, Kenneth E McCarson, Daniel T Christian, Vanja Duric

Abstract readReview
In one paragraph

Review in Biochemical pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tanner MagruderDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Marielle IsenhartDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Maximillian V StriepeDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Andrew MannistoDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Karry M JannieDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Jolene SmithDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Kenneth E McCarsonDepartment of Pharmacology, Toxicology and Experimental Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Daniel T ChristianDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Vanja DuricDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA. Electronic address: vanja.duric@dmu.edu.

Funding

GluD1 regulation of structural plasticity in chronic ethanol exposure and protracted withdrawalR03AA031063 · NIAAA · DES MOINES UNIV OSTEOPATHIC MEDICAL CTR · PI CHRISTIAN, DANIEL TOMMIS · 2023 to 2023
$152k
NIAAA NIH HHS R03 AA031063
6 · The paper itself

Abstract

Ketamine is a potent sedative and dissociative anesthetic agent that has been used clinically for over 50 years since it was first developed in the 1960 s as an alternative to phencyclidine (PCP). When compared to PCP, ketamine exhibited a much lower incidence of severe side effects, including hallucinations, leading to its increased popularity in clinical practice. Ketamine was initially used as an anesthetic agent, especially in emergency medicine and in surgical procedures where rapid induction and recovery was necessary. However, over the last few decades, ketamine was found to have additional clinically useful properties making it effective in the treatment of a variety of other conditions. Presently, ketamine has a wide range of clinical uses beyond anesthesia including management of acute and chronic pain, as well as treatment of psychiatric disorders such as major depression. In addition to various clinical uses, ketamine is also recognized as a common drug of abuse sought for its hallucinogenic and sedative effects. This review focuses on exploring the different clinical and non-clinical uses of ketamine and its overall impact on patient care.

Indexed as

Anesthetics, DissociativeKetamineAnimalsHallucinogensHumansAnesthetics, DissociativeHallucinogensKetamineAbuseAnalgesiaAnesthesiaAntidepressantHallucinogenKetamine

Identifiers

PMID39218043
PMCPMC11578541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.